Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bioharvest Sciences (BHST) Operating Leases (2023 - 2025)

Bioharvest Sciences has reported Operating Leases over the past 3 years, most recently at $1.4 million for Q4 2025.

  • For Q4 2025, Operating Leases rose 81.99% year-over-year to $1.4 million; the TTM value through Dec 2025 reached $1.4 million, up 81.99%, while the annual FY2025 figure was $1.4 million, 81.99% up from the prior year.
  • Operating Leases was $1.4 million for Q4 2025 at Bioharvest Sciences, down from $9.9 million in the prior quarter.
  • Across five years, Operating Leases topped out at $9.9 million in Q3 2025 and bottomed at $772000.0 in Q4 2024.
  • The 3-year median for Operating Leases is $1.7 million (2023), against an average of $4.9 million.
  • The widest YoY moves for Operating Leases: up 81.99% in 2025, down 88.44% in 2025.
  • Over 3 years, Operating Leases stood at $1.7 million in 2023, then tumbled by 55.56% to $772000.0 in 2024, then skyrocketed by 81.99% to $1.4 million in 2025.
  • The last three reported values for Operating Leases were $1.4 million (Q4 2025), $9.9 million (Q3 2025), and $1.5 million (Q2 2025) per Business Quant data.